Search Count: 14
 |
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm1010 (6-Cyclopropyl-2,4-Dimethyl-3-(4-(Trifluoromethyl)Benzyl)-2,6-Dihydro-7H-Pyrazolo[3,4-C]Pyridin-7-One)
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2025-01-29 Classification: OXIDOREDUCTASE Ligands: A1A5P, FMN, OG6 |
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION
Release Date: 2025-01-29
Ligands: A1A5P, FMN, OG6
 |
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm679 (Ethyl 1,4-Dimethyl-5-((6-(Trifluoromethyl)Pyridin-3-Yl)Methyl)-1H-Pyrazole-3-Carboxylate)
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION Resolution:2.41 Å Release Date: 2025-01-01 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: A1A51, FMN, OG6, CIT, LDA |
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: A1A51, FMN, OG6, CIT, LDA
 |
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm681 (N-Cyclopropyl-1,4-Dimethyl-5-((6-(Trifluoromethyl)Pyridin-3-Yl)Methyl)-1H-Pyrazole-3-Carboxamide)
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2025-01-01 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: A1A52, FMN, OG6, NA |
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: A1A52, FMN, OG6, NA
 |
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm959 (6-Cyclopropyl-2,4-Dimethyl-3-((6-(Trifluoromethyl)Pyridin-3-Yl)Methyl)-2,6-Dihydro-7H-Pyrazolo[3,4-C]Pyridin-7-One)
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2025-01-01 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: A1A53, FMN, OG6 |
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: A1A53, FMN, OG6
 |
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm1153 (4,6-Dicyclopropyl-3-(3-Fluoro-4-(Trifluoromethyl)Benzyl)-2-Methyl-2,6-Dihydro-7H-Pyrazolo[3,4-D]Pyridazin-7-One)
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION Resolution:3.15 Å Release Date: 2025-01-01 Classification: OXIDOREDUCTASE Ligands: A1A5Q, FMN, OG6 |
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: A1A5Q, FMN, OG6
 |
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm1174 (3-((7-Azaspiro[3.5]Nonan-7-Yl)Methyl)-4-Cyclopropyl-6-Ethyl-2-Methyl-2,6-Dihydro-7H-Pyrazolo[3,4-C]Pyridin-7-One)
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION Resolution:3.30 Å Release Date: 2025-01-01 Classification: OXIDOREDUCTASE Ligands: A1A59, FMN, OG6 |
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: A1A59, FMN, OG6
 |
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm1398 ((S)-3-(Amino(3-Chloro-4-(Trifluoromethyl)Phenyl)(Cyclopropyl)Methyl)-6-Cyclopropyl-2-Methyl-2,6-Dihydro-7H-Pyrazolo[3,4-D]Pyridazin-7-One)
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2025-01-01 Classification: OXIDOREDUCTASE Ligands: A1A6D, FMN, OG6, ACY |
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: A1A6D, FMN, OG6, ACY
 |
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm1211 ((R)-3-(Amino(6-(Trifluoromethyl)Pyridin-3-Yl)Methyl)-4-Cyclopropyl-6-Ethyl-2-Methyl-2,6-Dihydro-7H-Pyrazolo[3,4-C]Pyridin-7-One)
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2025-01-01 Classification: OXIDOREDUCTASE Ligands: A1A6E, FMN, OG6 |
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: A1A6E, FMN, OG6
 |
Usp7 In Complex With Ligand Compound 18
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.93 Å Release Date: 2020-04-29 Classification: HYDROLASE Ligands: R44, ACT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-04-29
Ligands: R44, ACT
 |
Usp7 In Complex With Ligand Compound 23
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.73 Å Release Date: 2020-04-29 Classification: HYDROLASE Ligands: R3Y |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-04-29
Ligands: R3Y
 |
Usp7 In Complex With Ligand Compound 1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.69 Å Release Date: 2020-04-29 Classification: HYDROLASE Ligands: R4D |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-04-29
Ligands: R4D
 |
Usp7 In Complex With Ligand Compound 7
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2020-04-29 Classification: HYDROLASE Ligands: R41 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-04-29
Ligands: R41
 |
Usp7 In Complex With Ligand Compound 14
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.99 Å Release Date: 2020-04-29 Classification: HYDROLASE Ligands: R4J, ZN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-04-29
Ligands: R4J, ZN
 |
Crystal Structure Of Human Dpp4 In Complex With A Noval Heterocyclic Dpp4 Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2012-02-08 Classification: HYDROLASE Ligands: N7F, NAG, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2012-02-08
Ligands: N7F, NAG, SO4